Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

lonidamine+levofloxacin lactate+Rhodamine B encapsulated in amphiphilic hyperbranched nanocapsules

Based on

1 Articles
2012 Most recent source

Composition

1

lonidamine

LND
Type Single Compound
Formula C15H10Cl2N2O2
Role core
2

levofloxacin lactate

LL
Type Single Compound
Formula C21H26FN3O7
Role core
3

9-(2-carboxyphenyl)-6-(diethylamino)-N,N-diethyl-3H-xanthen-3-iminium chloride

Rhodamine 610 Rhodamine B rhodamine B rhodamine-B Rhodamine rhodamine Rh 610 Rho B Rho-B RhoB Rhod Rho RDB RhB RB
Type Single Compound
Formula C28H31ClN2O3
Role core
4

poly (modified β-cyclodextrin)

Type Polymer
Formula
Role core
5

-C5H7N4O2

Type Single Compound
Formula -C5H7N4O2
Role layer

Properties

General physical and chemical properties

Property Value Source
fluorescence emission dependent on pH

More information available to subscribers only.

Or, view sample content

Applications

Characterization

Method Source
fluorescence spectroscopy

More information available to subscribers only.

Or, view sample content

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • 9-(2-carboxyphenyl)-6-(diethylamino)-N,N-diethyl-3H-xanthen-3-iminium chloride
  • lonidamine
  • levofloxacin lactate
  1. MmwJ4PcpD7nteXrAlkzE8B7b10040V4d
Product

lonidamine+levofloxacin lactate+Rhodamine B encapsulated in amphiphilic hyperbranched nanocapsules

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial